410.35
price up icon0.46%   1.88
after-market Dopo l'orario di chiusura: 410.35
loading

Natera Inc Borsa (NTRA) Ultime notizie

pulisher
Oct 01, 2026

After five sales in three months, a Natera (NTRA) officer proposes another stock sale. - Stock Titan

Oct 01, 2026
pulisher
Oct 01, 2026

Natera CEO Steve Chapman: Treatment on Molecular Recurrence Will Reshape Oncology in 5 Years - finance.biggo.com

Oct 01, 2026
pulisher
Sep 30, 2026

Natera, Inc. (NTRA) stock price, news, quote and history - Yahoo Finance Australia

Sep 30, 2026
pulisher
Sep 30, 2026

Natera, Inc. (NTRA) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 30, 2026
pulisher
Sep 30, 2026

Natera stock hits all-time high at 422.19 USD - Investing.com

Sep 30, 2026
pulisher
Sep 28, 2026

$1000 Invested In Natera 5 Years Ago Would Be Worth This Much Today - Benzinga

Sep 28, 2026
pulisher
Sep 28, 2026

Hewlett Packard, Natera, UnitedHealth Group: CNBC ‘Final Trades’UnitedHealth Group (NYSE:UNH) - Benzinga

Sep 28, 2026
pulisher
Sep 27, 2026

Form 4 Natera Inc For: 27 September By Investing.com - Investing.com Australia

Sep 27, 2026
pulisher
Sep 25, 2026

Form 4 Natera Inc For: 25 September By Investing.com - Investing.com Australia

Sep 25, 2026
pulisher
Sep 25, 2026

Form 4 Natera Inc For: 25 September - Investing.com India

Sep 25, 2026
pulisher
Sep 25, 2026

Natera director Sheena’s trusts dispose of $7.0m in NTRA stock - Investing.com

Sep 25, 2026
pulisher
Sep 25, 2026

Under a preset plan, two trusts sold 18,064 Natera (NTRA) shares in 12 transactions. - Stock Titan

Sep 25, 2026
pulisher
Sep 25, 2026

Natera(NTRA.US) Director Sells US$7.01 Million in Common Stock - Moomoo

Sep 25, 2026
pulisher
Sep 25, 2026

RBC Capital raises Natera stock price target on MRD testing growth By Investing.com - Investing.com South Africa

Sep 25, 2026
pulisher
Sep 25, 2026

Final Trades: Hewlett Packard, Natera and UnitedHealth - CNBC

Sep 25, 2026
pulisher
Sep 25, 2026

Natera options flow shows 12.6:1 put/call ratio near 52-week high - Investing.com

Sep 25, 2026
pulisher
Sep 25, 2026

NTRA Maintained by RBC Capital -- Price Target Raised to $460 - GuruFocus

Sep 25, 2026
pulisher
Sep 25, 2026

RBC Capital raises Natera stock price target on MRD testing growth - Investing.com

Sep 25, 2026
pulisher
Sep 25, 2026

Natera Is Maintained at Outperform by RBC Capital - moomoo.com

Sep 25, 2026
pulisher
Sep 25, 2026

RBC Capital maintains Outperform rating on Natera, $460 price target - TradingView

Sep 25, 2026
pulisher
Sep 25, 2026

Natera’s Critical Pivot to Oncology - Nanalyze

Sep 25, 2026
pulisher
Sep 25, 2026

RBC Raises Price Target on Natera to $460 From $350, Keeps Outperform Rating - marketscreener.com

Sep 25, 2026
pulisher
Sep 24, 2026

Natera Inc (NTRA) Stock Up 4.6% but GF Value Says Overvalued -- GF Score: 73/100 - GuruFocus

Sep 24, 2026
pulisher
Sep 24, 2026

Svetlana Nikic Celebrates Natera’s Signatera Milestone in Japan - Oncodaily

Sep 24, 2026
pulisher
Sep 24, 2026

Natera stock gains 2.75 percent after Japan test approval - AD HOC NEWS

Sep 24, 2026
pulisher
Sep 23, 2026

Has Natera (NTRA) Run Ahead Of Fair Value After Its Japan Signatera Approval? - simplywall.st

Sep 23, 2026
pulisher
Sep 23, 2026

Natera Director Sheena Jonathan to Offload 21,064 Shares Worth $8.16M, Form 144 Filed - Kalkine Media

Sep 23, 2026
pulisher
Sep 23, 2026

Stocks making big moves yesterday: AutoZone, Natera, Shopify, Twilio, and Lennar - Yahoo Finance

Sep 23, 2026
pulisher
Sep 23, 2026

Signatera Surges in Liquid Biopsy Race with New Lung Cancer Data and a Japan Approval - insideprecisionmedicine.com

Sep 23, 2026
pulisher
Sep 23, 2026

Form 144 Natera For: 23 September By Investing.com - Investing.com Canada

Sep 23, 2026
pulisher
Sep 23, 2026

Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx - Yahoo Finance

Sep 23, 2026
pulisher
Sep 23, 2026

$8.2M stock sale planned at Natera (NASDAQ: NTRA) - Stock Titan

Sep 23, 2026
pulisher
Sep 23, 2026

Natera, Inc.Signatera Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - marketscreener.com

Sep 23, 2026
pulisher
Sep 22, 2026

Why Is Natera (NTRA) Stock Soaring Today - Yahoo Finance

Sep 22, 2026
pulisher
Sep 22, 2026

A Look at Natera Inc (NTRA) After 5.5% Gain -- GF Value $219.69 vs Price $390.90 - GuruFocus

Sep 22, 2026
pulisher
Sep 22, 2026

Behavioral Patterns of NTRA and Institutional Flows - Stock Traders Daily

Sep 22, 2026
pulisher
Sep 22, 2026

Natera Inc stock reaches all-time high at 373.58 USD By Investing.com - Investing.com Nigeria

Sep 22, 2026
pulisher
Sep 22, 2026

Natera Inc Stock (NTRA) Moved Up by 5.67% on Sep 22: Facts Behind the Movement - TradingKey

Sep 22, 2026
pulisher
Sep 22, 2026

Natera gains as fresh Signatera lung cancer data and upbeat analyst sentiment support shares - Quiver Quantitative

Sep 22, 2026
pulisher
Sep 22, 2026

NTRA Looks 68.7% Overvalued on GF Value™ - gurufocus.com

Sep 22, 2026
pulisher
Sep 22, 2026

Signatera Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - Finviz

Sep 22, 2026
pulisher
Sep 22, 2026

Natera’s Signatera Receives Japanese Approval as CDx for Muscle-Invasive Bladder Cancer - GenomeWeb

Sep 22, 2026
pulisher
Sep 22, 2026

Natera Inc stock reaches all-time high at 373.58 USD - Investing.com

Sep 22, 2026
pulisher
Sep 22, 2026

Natera Says Signatera Commercial Launch In Japan Expected In 1H 2027 - TradingView

Sep 22, 2026
pulisher
Sep 22, 2026

Uber, Micron, Datadog And A Health Care Stock: CNBC’s ‘Final Trades’ - Benzinga

Sep 22, 2026
pulisher
Sep 22, 2026

A cancer test receives its second Japan approval in three months to guide bladder-cancer treatment. - Stock Titan

Sep 22, 2026
pulisher
Sep 21, 2026

Enterprise value to EBITDA ratio of Natera Inc Cert Deposito Arg Repr 0.019607 Sh – BCBA:NTRA.CI - TradingView

Sep 21, 2026
A A
$167.78
price up icon 0.66%
IQV IQV
$258.21
price down icon 0.96%
WAT WAT
$425.21
price down icon 0.08%
$273.04
price up icon 2.75%
$518.39
price up icon 0.12%
Capitalizzazione:     |  Volume (24 ore):